Composition:
One dose of the vaccine contains inactivated pathogen of hemorrhagic
disease of rabbits, strain BG-04 from 640 to 1280 HA.
Form of release:
Suspension.
Immunobiological properties:
Protection of rabbits from hemorrhagic disease for 12 months, protective antibodies
are produced from the fourth day after vaccination.
Target animals:
Rabbits.
Indications:
Used for the preventive immunization of rabbits against hemorrhagic
disease (HBD).
Interaction with other medicinal products
Do not mix with other medicinal and preventive preparations.
Dehelminthization of rabbits is carried out 2 weeks before vaccination or 2 weeks
after it. The vaccine can be used simultaneously with th